Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Large families can benefit from tailored zero based budgeting examples. Learn practical tips for managing expenses and maximizing income.
22,503 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
A decade of dividend growth and a tiny fee have made the Vanguard Dividend Appreciation ETF a standout for risk-aware...
A 20-year-old data analyst managing two jobs, a new gym venture with $80,000 in debt, and a newborn faces a burnout c...
As collections on federal student loans restart, Gen Z is bearing the cost with rising delinquencies and falling cred...
New research finds CFOs overseeing AI projects unlock significantly more value, with 76% reporting strong gains when ...
FuboTV has endured a brutal stretch as it tries to monetize a changing sports-media world. This deep dive weighs whet...
A 62-year-old retiree weighs a $500,000 Roth conversion over five years to reduce future RMDs, with an upfront tax bi...
Bitcoin briefly topped $80,000 again as traders weigh whether the move signals real demand or a looming reversal. Ana...
Investing hinges on leadership as much as numbers. This guide dives into how Josh D'Amaro's new approach could influe...
Bitcoin tops $80,000 again as Canaccord Genuity raises MicroStrategy’s price target to $224, highlighting a move towa...
Montauk’s early 2026 numbers offer critical clues for shareholders. This guide breaks down the montauk (mntk) 2026 ea...